A Study Comparing Use of Manual and Power Bone Marrow Aspiration and Biopsy Devices in Children
A Trial of the Vidacare Powered Bone Marrow Aspiration and Core Biopsy System (OnControl by Vidacare) Compared to Traditional Manual Devices in Children
1 other identifier
interventional
44
1 country
1
Brief Summary
The purpose of this study is to compare use of a powered bone marrow aspiration and biopsy device (OnControl) to use of a standard manual bone marrow aspiration and biopsy device to obtain bone marrow biopsy specimens in children. The hypothesis is that use of the powered device will improve the quantity and quality of bone marrow biopsy specimens when compared to the manual device.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 15, 2014
CompletedFirst Posted
Study publicly available on registry
June 9, 2014
CompletedResults Posted
Study results publicly available
August 25, 2014
CompletedJanuary 7, 2026
August 1, 2014
1.1 years
May 15, 2014
July 15, 2014
December 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Percent of Hematopoietic Tissue Present in Bone Marrow Biopsy Specimens Obtained Using the Manual Device and Powered Device
Bone marrow biopsy specimens will be evaluated by a blinded pathologist and measured for percent of hematopoietic tissue present. Higher percentage of hematopoietic tissue present in a biopsy specimen indicates a larger quantity of specimen for pathological evaluation.
within 24 hours of bone marrow sampling procedure
Secondary Outcomes (8)
Bone Marrow Biopsy Specimen Size (Length) Obtained Using the Manual Device and the Powered Device
within 24 hours of the bone marrow sampling procedure
Bone Marrow Biopsy Specimen Size (Width) Obtained Using the Manual Device and the Powered Device
within 24 hours of the bone marrow sampling procedure
Bone Marrow Biopsy Specimen Size (Volume) Obtained Using the Manual Device and the Powered Device
within 24 hours of the bone marrow sampling procedure
Bone Marrow Biopsy Specimen Capture Rate for the Manual Device and the Powered Device
at time of the bone marrow sampling procedure
Amount of Time Lapsed From Needle to Skin Contact to Bone Marrow Aspiration Specimen Acquisition Using the Manual Device and the Powered Device
at time of the bone marrow sampling procedure
- +3 more secondary outcomes
Study Arms (2)
Manual bone marrow aspiration and biopsy procedure
ACTIVE COMPARATORManual bone marrow aspiration and biopsy device
Powered bone marrow aspiration and biopsy procedure
ACTIVE COMPARATORPowered bone marrow aspiration and biopsy device
Interventions
Use of the powered bone marrow aspiration and biopsy device to collect bone marrow aspiration specimens and bone marrow biopsy specimens.
Use of the manual bone marrow aspiration and biopsy device to collect bone marrow aspiration and bone marrow biopsy specimens.
Eligibility Criteria
You may qualify if:
- Informed consent and assent for minors over the age of seven years must be obtained before any trial-related activities are initiated
- Patients requiring bone marrow aspirations and/or biopsies as part of standard diagnosis and treatment
- Treated at Christus Santa Rosa Children's hospital
- Age 2 to 18 years
- Male or female
- Supportive family with willingness to participate in completing questionnaires
- English or Spanish primary language
You may not qualify if:
- Patients who are pregnant
- Patients with hemorrhagic disorders such as congenital coagulation factor deficiencies disseminated intravascular coagulation and concomitant use of anticoagulants
- Patients with a skin infection or recent radiation therapy at the sampling site
- Patients with bone disorders such as osteomyelitis or osteogenesis imperfecta
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Christus Santa Rosa Children's Hospital
San Antonio, Texas, 78207, United States
Results Point of Contact
- Title
- Chatchawin Assanasen, MD
- Organization
- The University of Texas Health Science Center
Study Officials
- PRINCIPAL INVESTIGATOR
Chatchawin Assanasen, MD
Christus Santa Rosa Children's Hospital
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Pediatric Hematology/Oncology
Study Record Dates
First Submitted
May 15, 2014
First Posted
June 9, 2014
Study Start
April 1, 2012
Primary Completion
May 1, 2013
Study Completion
May 1, 2013
Last Updated
January 7, 2026
Results First Posted
August 25, 2014
Record last verified: 2014-08